ArticleHaematologica2021

Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse.

Esther Onecha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.